Telum Therapeutics

Telum Therapeutics
Biotechnology company developing novel protein-based antimicrobial therapeutics.
About
Technology stack
detected 2026-07-05No comments yet. Be the first to share your take.
What does Telum Therapeutics do?
Telum Therapeutics is a Spanish biotechnology company focused on developing a new class of antimicrobial therapies to combat difficult-to-treat infections, particularly hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP). Their lead program targets Acinetobacter baumannii, a multidrug-resistant pathogen. The company's proprietary APEX platform is designed to create biologically derived, protein-based therapeutics that aim to overcome the limitations…
How much funding has Telum Therapeutics raised?
Telum Therapeutics has raised a total of $21M in funding. The most recent round on record is Series A.
Where is Telum Therapeutics headquartered?
Telum Therapeutics is headquartered in Navarra, Spain.
When was Telum Therapeutics founded?
Telum Therapeutics was founded in 2019.
What industry does Telum Therapeutics operate in?
Telum Therapeutics operates in Biotechnology, Pharmaceuticals, Drug Discovery, Antimicrobial Resistance, Biotech, Antimicrobial Therapeutics.
What is Telum Therapeutics's revenue?
StartupHub estimates Telum Therapeutics's annual revenue at $2.6M (range $683K to $8.8M, 37% confidence), based on comparable companies in the sector.
What is Telum Therapeutics's valuation?
StartupHub estimates Telum Therapeutics's effective valuation at $80.2M (range $52.5M to $126.0M, 25% confidence), based on comparable companies in the sector.